Literature DB >> 19061754

Chikungunya: a paradigm of emergence and globalization of vector-borne diseases.

Fabrice Simon1, Hélène Savini, Philippe Parola.   

Abstract

Chikungunya (CHIK) fever is a tropical arboviral disease responsible for acute polyarthritis which can last for weeks to months. In 2007, the chikungunya virus (CHIKV) reached Europe. Since the beginning of this outbreak, several million cases of chikungunya virus disease have occurred in autochthonous populations and in travelers who were diagnosed after they returned home from epidemic areas. CHIKV, usually transmitted by Aedes aegypti mosquitoes, has now been repeatedly associated with a new vector, Aedes albopictus (the "Asian tiger mosquito"), which has spread into tropical areas previously occupied predominantly by A aegypti, and has dispersed worldwide. Because CHIKV could spread throughout the world, all physicians should be prepared to encounter this arboviral infection, which represents a paradigm for emerging arboviral infections. In this article, the authors review different aspects of this reemerging and fascinating disease, focusing on clinical aspects and lessons from the recent large-scale outbreaks.

Entities:  

Mesh:

Year:  2008        PMID: 19061754     DOI: 10.1016/j.mcna.2008.07.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  41 in total

1.  Acquired auditory neuropathy spectrum disorder after an attack of chikungunya: case study.

Authors:  Prashanth Prabhu
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-03       Impact factor: 2.503

2.  Case reports of neuro-Chikungunya in southern Thailand.

Authors:  Sarunyou Chusri; Pisud Siripaitoon; Siriporn Hirunpat; Khachornsakdi Silpapojakul
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

3.  Pathogenicity of life-shortening Wolbachia in Aedes albopictus after transfer from Drosophila melanogaster.

Authors:  Eunho Suh; David R Mercer; Yuqing Fu; Stephen L Dobson
Journal:  Appl Environ Microbiol       Date:  2009-10-09       Impact factor: 4.792

4.  Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions.

Authors:  Ryan M Kramer; Yuhong Zeng; Neha Sahni; Lisa A Kueltzo; Richard M Schwartz; Indresh K Srivastava; Lindsey Crane; Sangeeta B Joshi; David B Volkin; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2013-10-15       Impact factor: 3.534

5.  A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

Authors:  Juan García-Arriaza; Victoria Cepeda; David Hallengärd; Carlos Óscar S Sorzano; Beate Mareike Kümmerer; Peter Liljeström; Mariano Esteban
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

6.  γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease.

Authors:  Kristin M Long; Martin T Ferris; Alan C Whitmore; Stephanie A Montgomery; Lance R Thurlow; Charles E McGee; Carlos A Rodriguez; Jean K Lim; Mark T Heise
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

7.  Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic.

Authors:  Alladi Mohan; D H N Kiran; I Chiranjeevi Manohar; D Prabath Kumar
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 8.  Chikungunya: a potentially emerging epidemic?

Authors:  Michelle M Thiboutot; Senthil Kannan; Omkar U Kawalekar; Devon J Shedlock; Amir S Khan; Gopalsamy Sarangan; Padma Srikanth; David B Weiner; Karuppiah Muthumani
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

9.  Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes.

Authors:  Konstantin A Tsetsarkin; Charles E McGee; Sara M Volk; Dana L Vanlandingham; Scott C Weaver; Stephen Higgs
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

10.  Establishment of one-step SYBR green-based real time-PCR assay for rapid detection and quantification of chikungunya virus infection.

Authors:  Phui San Ho; Mary Mah Lee Ng; Justin Jang Hann Chu
Journal:  Virol J       Date:  2010-01-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.